While the world focuses on the COVID-19 pandemic and the rollout and distribution of a vaccine against the virus, the Ebola virus, which killed thousands in West Africa between 2014 and 2016, has reappeared. On February seventh, the Democratic Republic of Congo confirmed four cases of the virus, and five Guineans have died of the disease over the past week, prompting Guinea’s government to declare a pandemic. However, unlike the early days of COVID-19 , there is already an effective Ebola vaccine that so far have helped contain outbreaks where they occur.

To find out more about the development of the Ebola vaccine, its effectiveness and how it is used, VOA’s Adam Phillips spoke with ICAP’s Tiffany Harris, PhD, MS. She is a professor of epidemiology at Columbia University Medical Center in New York, and the director of Strategic Information at ICAP.

Listen to the full recording on Soundcloud